查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1750819

美国腹部疝气网片市场规模、份额、趋势分析报告（按网片类型、适应症、手术、最终用途、细分市场预测，2025-2030 年）

U.S. Ventral Hernia Mesh Devices Market Size, Share & Trends Analysis Report By Mesh Type (Resorbable, Partially Absorbable), By Indication (Umbilical Hernia, Epigastric Hernia), By Procedure, By End Use, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 140 Pages | 商品交期: 2-10个工作天内

价格

市场规模与趋势：

预计 2024 年美国腹壁疝气网片市场价值将达到 3.567 亿美元，预计 2025 年至 2030 年的复合年增长率为 8.27%。

疝气病例的增加、网片修復技术的进步、向预防性医疗保健的转变、对微创手术的偏好日益增长以及医疗保健基础设施的不断增长都是影响市场增长的因素。根据美国FDA 的数据，美国每年进行超过一百万例疝气修补手术。

疝气修补术是全球最常见的外科手术之一。男性疝气发生率高于女性。根据《国际外科杂誌》报道，每年约有 30 万例腹部疝气修復术。其中，75% 为原发性腹疝气（主要为上腹部和脐疝气），25% 为切口疝气。此外，在美国，近 10% 至 30% 接受中线开放性手术的患者常见于切口疝气。疝气修补术的年度费用估计约为 32 亿美元。这对患者来说是一项重大的医疗保健挑战，也是美国医疗保健系统的主要财务障碍。

腹部疝气网片的优惠报销方案鼓励患者选择手术。政府和行业相关人员为患者提供易于取得的详细报销代码和比例。代码依疝气类型（原发性vs 復发性疝气）和手术方式（开放性手术 vs 腹腔镜手术）分类。

腹疝气补片的技术进步显着改善了患者的预后并减少了併发症。其中一项显着的创新是轻质复合补片的开发。这些补片，例如Parietex复合补片，结合了可吸收和不可吸收材料，在提供强度的同时，降低了术后不适和慢性疼痛的风险。这些进步也包括Deep Blue Medical Advances, Inc.的先进补片技术等创新。 2024年，该公司推出了T-Line Mini，这是其T-Line补片的缩小版，用于脐疝气和小缺损。此外，其T-Line补片的涂层和生物合成复合材料版本正在开发中。

目录

第一章调查方法与范围

第二章执行摘要

第三章美国腹部疝气网片市场变数、趋势与范围

  • 市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
  • 美国腹部疝气网片市场分析工具
    • 产业分析-波特五力分析
    • PESTEL分析

第四章美国腹部疝气网片市场：按网片类型进行的估计和趋势分析

  • 细分仪表板
  • 美国腹疝气网片市场：网片类型波动分析
  • 美国腹部疝气网片市场：按网片类型分類的展望
  • 2018年至2030年市场规模、预测及趋势分析
  • 可吸收网片
  • 部分吸收网
  • 不可吸收网片

第五章美国腹部疝气网片市场（按适应症）：估计与趋势分析

  • 细分仪表板
  • 美国腹疝气网片市场：适应症差异分析
  • 美国腹部疝气网片市场（按适应症）：展望
  • 2018年至2030年市场规模、预测及趋势分析
  • 脐疝气
  • 上腹疝
  • 切口疝气
  • 其他的

第六章。美国腹部疝气网片市场（按程序）：估计和趋势分析

  • 细分仪表板
  • 美国腹部疝气网片市场：依程序进行的变化分析
  • 美国腹部疝气网片市场（依手术类型）展望
  • 2018年至2030年市场规模、预测及趋势分析
  • 开放性手术
  • 腹腔镜手术
  • 机器人手术
  • 其他的

第七章美国腹部疝气网片市场：按最终用途的估计和趋势分析

  • 细分仪表板
  • 美国腹疝气网片市场：依最终用途进行的变化分析
  • 美国腹疝气网片市场：最终用途展望
  • 2018年至2030年市场规模、预测及趋势分析
  • 住院设施
  • 门诊设施

第八章 竞争态势

  • 市场参与企业分类
  • 2024年企业市场分析
  • 主要企业简介
    • Medtronic plc
    • Becton, Dickinson and Company
    • Ethicon Inc.（Johnson &Johnson MedTech）
    • Meril Life Sciences Pvt. Ltd.
    • Novus Scientific AB
    • B. Braun SE
    • TELA Bio, Inc.
    • BG Medical LLC
    • Integra LifeSciences Corporation
    • WL Gore &Associates, Inc.
    • Atrium Medical
Product Code: GVR-4-68040-575-6

Market Size & Trends:

The U.S. ventral hernia mesh devices market size was estimated at USD 356.7 million in 2024 and is projected to grow at a CAGR of 8.27% from 2025 to 2030. The increasing cases of hernias, technological advancements in mesh repair, a shift towards preventive healthcare, growing preference for minimally invasive procedures, and a growing healthcare infrastructure are the factors affecting market growth. According to the U.S. FDA, over a million hernia repair procedures are performed annually in the U.S.

Hernia repair is one of the most common surgical procedures worldwide. The incidence of hernia is higher in men than in women. According to the International Journal of Surgery, approximately 300,000 ventral hernia repairs are performed annually. Among these, 75% are primary ventral hernia repairs (mainly epigastric and umbilical) and 25% are incisional hernia repairs. Furthermore, incisional hernias are common in nearly 10-30% of patients in the U.S. who undergo midline laparotomies. The annual costs for hernia repairs are estimated at approximately USD 3.2 billion. This is viewed as a major healthcare challenge for patients and a significant financial hurdle for the U.S. healthcare system.

The presence of favorable reimbursement scenarios for hernia mesh devices is encouraging patients to opt for surgery. The government and industry players provide patients with easy access to detailed reimbursement codes and ratios. The codes are granulated into types of hernias (primary or recurrent) and surgery methods (open or laparoscopic).

Technological advancements in hernia mesh devices have significantly improved patient outcomes and reduced complications. One notable innovation is the development of lightweight and composite meshes. These meshes, such as Parietex Composite Mesh, combine absorbable and nonabsorbable materials, providing strength while reducing postoperative discomfort and the risk of chronic pain. These advancements include innovations like Deep Blue Medical Advances, Inc.'s advanced mesh technology. In 2024, the company launched a smaller version of the T-Line Mesh, known as the T-Line Mini, tailored for umbilical hernias and small defects. Moreover, the T-Line Hernia Mesh's coated and biosynthetic composite versions are developing.

U.S. Ventral Hernia Mesh Devices Market Report Segmentation

This report forecasts country-level revenue growth and analyzes the latest industry trends and opportunities in each sub-segment from 2018 to 2030. For this study, Grand View Research has segmented the U.S. ventral hernia mesh devices market report based on mesh type, indication, procedure, and end use:

  • Mesh Type Outlook (Revenue, USD Million, 2018 - 2030)
  • Resorbable Mesh
  • Partially Absorbable Mesh
  • Non-resorbable Mesh
  • Indication Outlook (Revenue, USD Million 2018 - 2030)
  • Umbilical Hernia
  • Epigastric Hernia
  • Incisional Hernia
  • Others
  • Procedure Outlook (Revenue, USD Million 2018 - 2030)
  • Open Surgery
  • Laparoscopic Surgery
  • Robotic Surgery
  • Others
  • End Use Outlook (Revenue, USD Million 2018 - 2030)
  • Inpatient Facilities
  • Outpatient Facilities

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Segment Definitions
    • 1.2.1. Mesh Type
    • 1.2.2. Indication
    • 1.2.3. Procedure
    • 1.2.4. End Use
    • 1.2.5. Estimates and forecasts timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
      • 1.4.5.1. Data for primary interviews in the U.S.
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Approach 1: Commodity flow approach
    • 1.7.3. Volume price analysis (Model 2)
    • 1.7.4. Approach 2: Volume price analysis
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Mesh Type outlook
    • 2.2.2. Indication outlook
    • 2.2.3. Procedure outlook
    • 2.2.4. End-use outlook
  • 2.3. Regional outlook
  • 2.4. Competitive Insights

Chapter 3. U.S. Ventral Hernia Mesh Devices Market Variables, Trends & Scope

  • 3.1. Market Dynamics
    • 3.1.1. Market Driver Analysis
      • 3.1.1.1. Global Shift Toward Preventive Healthcare
      • 3.1.1.2. Supportive Government Policies
      • 3.1.1.3. Increasing Incidence of Hernias
      • 3.1.1.4. Technological Advancements in Mesh Repair
      • 3.1.1.5. Growing Preference for Minimally Invasive Procedures
    • 3.1.2. Market Restraint Analysis
      • 3.1.2.1. Complications Related to Mesh Implants
      • 3.1.2.2. High Costs of Advanced Meshes
      • 3.1.2.3. Product Recalls
  • 3.2. U.S. Ventral Hernia Mesh Devices Market Analysis Tools
    • 3.2.1. Industry Analysis - Porter's
      • 3.2.1.1. Bargaining power of suppliers
      • 3.2.1.2. Bargaining power of buyers
      • 3.2.1.3. Threat of substitutes
      • 3.2.1.4. Threat of new entrants
      • 3.2.1.5. Competitive rivalry
    • 3.2.2. PESTEL Analysis
      • 3.2.2.1. Political landscape
      • 3.2.2.2. Economic landscape
      • 3.2.2.3. Social landscape
      • 3.2.2.4. Technological landscape
      • 3.2.2.5. Environmental Landscape
      • 3.2.2.6. Legal Landscape

Chapter 4. U.S. Ventral Hernia Mesh Devices Market: Mesh Type Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. U.S. Ventral Hernia Mesh Devices Market: Mesh Type Movement Analysis
  • 4.3. U.S. Ventral Hernia Mesh Devices Market by Mesh Type Outlook (USD Million)
  • 4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 4.5. Resorbable Mesh
    • 4.5.1. Resorbable Mesh Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.6. Partially Absorbable Mesh
    • 4.6.1. Partially Absorbable Mesh Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.7. Non-resorbable Mesh
    • 4.7.1. Non-resorbable Mesh Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. U.S. Ventral Hernia Mesh Devices Market: Indication Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. U.S. Ventral Hernia Mesh Devices Market: Indication Movement Analysis
  • 5.3. U.S. Ventral Hernia Mesh Devices Market by Indication Outlook (USD Million)
  • 5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 5.5. Umbilical Hernia
    • 5.5.1. Umbilical Hernia Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.6. Epigastric Hernia
    • 5.6.1. Epigastric Hernia Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.7. Incisional Hernia
    • 5.7.1. Incisional Hernia Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.8. Others
    • 5.8.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. U.S. Ventral Hernia Mesh Devices Market: Procedure Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. U.S. Ventral Hernia Mesh Devices Market: Procedure Movement Analysis
  • 6.3. U.S. Ventral Hernia Mesh Devices Market by Procedure Outlook (USD Million)
  • 6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 6.5. Open Surgery
    • 6.5.1. Open Surgery Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6. Laparoscopic Surgery
    • 6.6.1. Laparoscopic Surgery Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.7. Robotic Surgery
    • 6.7.1. Robotic Surgery Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.8. Others
    • 6.8.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. U.S. Ventral Hernia Mesh Devices Market: End-use Estimates & Trend Analysis

  • 7.1. Segment Dashboard
  • 7.2. U.S. Ventral Hernia Mesh Devices Market: End-use Movement Analysis
  • 7.3. U.S. Ventral Hernia Mesh Devices Market by End-use Outlook (USD Million)
  • 7.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 7.5. Inpatient Facilities
    • 7.5.1. Inpatient Facilities Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.6. Outpatient Facilities
    • 7.6.1. Outpatient Facilities Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Market Participant Categorization
  • 8.2. Company Market Position Analysis, 2024
  • 8.3. Key Company Profiles
    • 8.3.1. Medtronic plc
      • 8.3.1.1. Company overview
      • 8.3.1.2. Financial performance
      • 8.3.1.3. Product benchmarking
      • 8.3.1.4. Strategic initiatives
    • 8.3.2. Becton, Dickinson and Company
      • 8.3.2.1. Company overview
      • 8.3.2.2. Financial performance
      • 8.3.2.3. Product benchmarking
      • 8.3.2.4. Strategic initiatives
    • 8.3.3. Ethicon Inc. (Johnson & Johnson MedTech)
      • 8.3.3.1. Company overview
      • 8.3.3.2. Financial performance
      • 8.3.3.3. Product benchmarking
      • 8.3.3.4. Strategic initiatives
    • 8.3.4. Meril Life Sciences Pvt. Ltd.
      • 8.3.4.1. Company overview
      • 8.3.4.2. Financial performance
      • 8.3.4.3. Product benchmarking
      • 8.3.4.4. Strategic initiatives
    • 8.3.5. Novus Scientific AB
      • 8.3.5.1. Company overview
      • 8.3.5.2. Financial performance
      • 8.3.5.3. Product benchmarking
      • 8.3.5.4. Strategic initiatives
    • 8.3.6. B. Braun SE
      • 8.3.6.1. Company overview
      • 8.3.6.2. Financial performance
      • 8.3.6.3. Product benchmarking
      • 8.3.6.4. Strategic initiatives
    • 8.3.7. TELA Bio, Inc.
      • 8.3.7.1. Company overview
      • 8.3.7.2. Financial performance
      • 8.3.7.3. Product benchmarking
      • 8.3.7.4. Strategic initiatives
    • 8.3.8. BG Medical LLC
      • 8.3.8.1. Company overview
      • 8.3.8.2. Financial performance
      • 8.3.8.3. Product benchmarking
      • 8.3.8.4. Strategic initiatives
    • 8.3.9. Integra LifeSciences Corporation
      • 8.3.9.1. Company overview
      • 8.3.9.2. Financial performance
      • 8.3.9.3. Product benchmarking
      • 8.3.9.4. Strategic initiatives
    • 8.3.10. W. L. Gore & Associates, Inc.
      • 8.3.10.1. Company overview
      • 8.3.10.2. Financial performance
      • 8.3.10.3. Product benchmarking
      • 8.3.10.4. Strategic initiatives
    • 8.3.11. Atrium Medical
      • 8.3.11.1. Company overview
      • 8.3.11.2. Financial performance
      • 8.3.11.3. Product benchmarking
      • 8.3.11.4. Strategic initiatives

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviations
  • Table 3 U.S. ventral hernia mesh devices market, by mesh type, 2018 - 2030 (USD Million)
  • Table 4 U.S. ventral hernia mesh devices market, by indication, 2018 - 2030 (USD Million)
  • Table 5 U.S. ventral hernia mesh devices market, by procedure, 2018 - 2030 (USD Million)
  • Table 6 U.S. ventral hernia mesh devices market, by end use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Information Procurement
  • Fig. 2 Primary Research Pattern
  • Fig. 3 Market Research Approaches
  • Fig. 4 Value Chain-Based Sizing & Forecasting
  • Fig. 5 Market Formulation & Validation
  • Fig. 6 US ventral hernia mesh devices market segmentation
  • Fig. 7 Market driver analysis (Current & future impact)
  • Fig. 8 Market restraint analysis (Current & future impact)
  • Fig. 9 Market opportunity analysis (Current & future impact)
  • Fig. 10 SWOT Analysis by Factor (Political & Legal, Economic, and Technological)
  • Fig. 11 Porter's Five Forces Analysis
  • Fig. 12 US Ventral hernia mesh devices market, mesh type outlook key takeaways (USD Million)
  • Fig. 13 US Ventral hernia mesh devices market: mesh type movement analysis, 2023 & 2030 (USD Million)
  • Fig. 14 Resorbable mesh market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 15 Partially absorbable mesh market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 16 Non-resorbable mesh market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 17 U.S. Ventral hernia mesh devices market, indication outlook key takeaways (USD Million)
  • Fig. 18 U.S. Ventral hernia mesh devices market: indication movement analysis, 2023 & 2030 (USD Million)
  • Fig. 19 Umbilical hernia market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 20 Epigastric hernia market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 21 Incisional hernia market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 22 Others market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 23 U.S. Ventral hernia mesh devices market, procedure outlook key takeaways (USD Million)
  • Fig. 24 U.S. Ventral hernia mesh devices market: procedure movement analysis, 2023 & 2030 (USD Million)
  • Fig. 25 Open surgery market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 26 Laparoscopic surgery market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 27 Robotic surgery market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 28 Others market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 29 U.S. Ventral hernia mesh devices market, end use outlook key takeaways (USD Million)
  • Fig. 30 U.S. Ventral hernia mesh devices market: end use movement analysis, 2023 & 2030 (USD Million)
  • Fig. 31 Inpatient facilities market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 32 Outpatient facilities market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 33 List of key emerging companies/technology disruptors/innovators